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Suprarenal aortic cross-clamp position: A
reappraisal of its effects on outcomes for open
abdominal aortic aneurysm repair
Tec Chong, MD, Louis Nguyen, MD, MPH, MBA, Christopher D. Owens, MD, Michael S. Conte, MD,
and Michael Belkin, MD, Boston, Mass
Objectives:With the increasing use of endovascular aneurysm repair, a greater proportion of open aneurysm repairs in the
future are expected to be more complex and require suprarenal cross-clamping. We sought to evaluate the effects of
suprarenal (SR) vs infrarenal (IR) aortic cross-clamp position in abdominal aortic aneurysm (AAA) repair in an updated
single center series.
Methods: All elective open AAA repairs performed at our institution between 1990 and 2006 were entered into a
prospective database and reviewed retrospectively. Our main stratification variable was SR vs IR. The SR group was
further subdivided into those requiring an adjunctive renal revascularization procedure (SRRRP; n  54) and those
who did not (SRRRP; n 117). Univariate andmultivariate models were used to analyze the effect of baseline variables
and operative variables on our primary endpoint 30-day mortality as well as secondary endpoints such as major adverse
events, postoperative decline in renal function (defined as doubling of baseline creatinine to level >2 mg/dL, or
new-onset dialysis) and long-term survival. A propensity score model was developed to control for confounding variables
associated with the use of an SR cross-clamp.
Results:A total of 1020 patients underwent elective AAA repair, of which 849 (83.2%) were IR and 171 (16.8%) were SR.
Diabetes (14.6% vs 9.1%, P  .027), hypertension (70.2% vs 61.4%, P  .03), and chronic renal failure (14.0% vs 4.7%,
P  .001) were more prevalent in the SR group, and mean aneurysm size was larger (6.0 cm vs 5.6 cm, P  .001).
Estimated blood loss was higher (1919mL vs 1257mL, P .001) in the SR group, as was mean length of stay (12.6 days
vs 10.7 days, P .047). Perioperative (30-day) mortality rate was 1.8% for the SR group and 1.2% for the IR group (P
.44). Postoperative decline in renal function was 17.0% in SR vs 9.5% in IR (P  .003), however, new-onset dialysis was
rare (0.6% SR, 0.8% IR, P  NS). The combination of SRRRP was associated with an increased risk for postoperative
decline in renal function (14.8% SRRRP, 4.3% SRRRP, P  .016). Preoperative renal failure was strongly associated
with postoperative renal decline (odds ratio [OR] 8.15, 2.92-22.8, P < .0001). Propensity score analysis demonstrated
that the use of an SR cross-clamp was associated with an increased risk for postoperative renal decline (OR 2.66,
1.28-5.50, P  .009). Major adverse events were more prevalent in the SR group compared to the IR group (17.0% vs
9.5%, P  .003). Five-year survival was 69.1%  1.9% for the IR group and 67.7%  4.3% for the SR group (P  0.38)
by life table analysis.
Conclusion: Suprarenal cross-clamping is associated with low mortality and significant but acceptable morbidity,
including postoperative decline in renal function. The results from this series may serve as relevant background data when
evaluating emerging branched and fenestrated endograft technologies. ( J Vasc Surg 2009;49:873-80.)The majority of abdominal aortic aneurysms (AAAs)
are infrarenal (IR) which allows control of the aorta via an
IR aortic cross-clamp. The use of a suprarenal (SR) cross-
clamp has been associated with increased morbidity and
mortality. Crawford et al1 in 1986 described the first report
on the results of SR cross-clamping in open aneurysm repair
in 101 patients. They noted a 7.9%mortality rate and an 8%
postoperative incidence of dialysis. Similar reports have
appeared in the literature. Sarac et al2 described the expe-
rience of The Cleveland Clinic in 138 juxta renal aneurysm
repairs and noted a 5.1%mortality rate, a 28% postoperative
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doi:10.1016/j.jvs.2008.10.057renal insufficiency rate, and a 5.8% dialysis-dependence
rate. More recently, West et al3 reviewed the experience at
the Mayo Clinic on 247 pararenal AAAs and found a 2.5%
mortality rate and 3.7% dialysis rate.
In the current era, most centers are repairing IR AAAs
utilizing endovascular options. As a result, an increasing
proportion of open AAAs in the US require an SR aortic
cross-clamp. Costin et al4 concluded that the complexity of
open AAA repair has increased in the era of endovascular
stent grafting which included a greater proportion of pa-
tients requiring an SR cross-clamp and division of the left
renal vein. Thus, we undertook this study to provide data
on a series of patients requiring an SR cross-clamp and
compare them to an updated cohort of patients who had an
IR aneurysm repair. With the advent of newer stent graft
technologies, there is great interest in exploring the use of
fenestrated or branched endografts for the repair of juxta-
renal and SR AAAs. This study also serves as an updated
evaluation of open surgery for the comparative evalua-
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METHODS
We reviewed all elective open infrarenal and juxtarenal/
SR AAA repairs performed at the Brigham and Women’s
Hospital between 1990 and 2006. The results of these
procedures were reviewed retrospectively from a prospec-
tively maintained database in the Division of Vascular Sur-
gery. Operative notes were reviewed for cross-clamp loca-
tion (IR or SR) and data were gathered from review of the
medical records. Suprarenal cross-clamp location is defined
as clamping above both main renal arteries. This clamp
location was determined by the surgeon’s preference, the
presence of calcification, intraluminal thrombus, and ana-
tomic suitability based on the aneurysm proximity to the
renal arteries. Type 4 thoracoabdominal aneurysms were
excluded from this study. The SR group was then subdi-
vided into those that required a simultaneous adjunctive
renal revascularization procedure (SRRRP; aortorenal
bypass, reimplantation of the renal artery, or renal endar-
terectomy) and those that did not (SRRRP).
The open aneurysm repair was carried out via a trans-
peritoneal or retroperitoneal approach at the surgeon’s
discretion. Auto-transfusion devices were routinely used.
Anesthesia protocols were standardized and included a
combination of epidural and general anesthesia in all
cases (unless the epidural was contraindicated). Routine
-blockade has become standard (assuming no contraindi-
cation) over the past decade. This medication is started at
our preoperative clinic to achieve a target heart rate of 60
beats per minute. Patients in the SR group routinely re-
ceived intraoperative mannitol (1g/kg) 15minutes prior to
cross-clamping and 100mg of furosemide 10minutes prior
to cross-clamping. We believe that mannitol acts as a free
radical scavenger5,6 while furosemide decreases renal tubu-
lar oxygen demand.7 Patients in the IR group received only
mannitol 15 minutes prior to cross-clamping at 0.5 g/kg
dose. If the preoperative creatinine value was greater than 2
mg/dL then an equivalent dose was given 15 minutes after
unclamping. Invasive monitoring includes an arterial line
and central venous access for all cases.
Baseline variables that were captured included size of
aneurysm, gender, age, and preoperative risk factors includ-
ing diabetes, smoking (current), hypertension (diastolic
blood pressure90 mmHg, or on one or more antihyper-
tensive medications), coronary artery disease (history of
myocardial infarction, coronary revascularization, or ab-
normal stress test), prior coronary artery bypass surgery,
cerebrovascular disease (history of stroke, transient isch-
emic attack, or carotid surgery), chronic pulmonary disease
(patient on supplemental oxygen or pulmonary function
tests less than 80% of predicted), chronic renal failure, and
congestive heart failure (data from cardiology report). Pre-
operative renal failure was defined as serum creatinine2.0
mg/dL or dialysis dependence. Procedural variables recov-
ered from the database included estimated blood loss
(EBL), length of stay (LOS), and serum creatinine. Creat-inine levels were recorded from two time intervals; preop-
eratively and within 24 hours of discharge. All of these
preoperative variables were included in our multivariable
analysis model.
A more detailed analysis of renal function by calcu-
lating Glomerular Filtration Rate (GFR) was performed
using the simplified Modification of Diet in Renal Dis-
ease (MDRD) equation. This is calculated using the for-
mula GFR 186 * Creatinine1.154 * Age0.203 * 1.21 (if
patient is African American) * 0.742 (if female)8. Using the
GFR, postoperative renal failure was defined as GFR 30
mL/minute/1.73 m2 and a 20% decrease from preoper-
ative GFR levels.
Postoperative morbidity variables that were captured
included cardiovascular complications (myocardial infarc-
tion defined as electrocardiogram [EKG] changes from
baseline and elevation of cardiac enzymes to more than
twice the upper limit of normal and verified by a staff
cardiologist, arrhythmia, congestive heart failure), periph-
eral emboli, decline in renal function, pneumonia,
stroke, reoperation for hemorrhage, wound dehiscence,
deep venous thrombosis, wound infection, coagulopa-
thy, hematoma/seroma, and gastrointestinal complica-
tions (protracted ileus, ischemic colon, gastrointestinal
bleed, pancreatitis, and hepatic failure). Postoperative de-
cline in renal function was defined as doubling of preoper-
ative creatinine to levels 2.0 mg/dL or new-onset dialy-
sis. Patients who already have preoperative renal failure are
not included in the postoperative renal decline analysis.
Our primary endpoints were 30-day mortality and
postoperative morbidity focusing on renal function. The
secondary endpoints were postoperative morbidity focus-
ing specifically on postoperative decline in renal function,
major adverse events (MAE) and long-term survival. The
main stratification variable in this study was the location of
the aortic cross-clamp. Subset analyses of concomitant re-
nal revascularization procedures were also performed.
Bivariate analyses of patient and operative factors asso-
ciated with IR or SR clamping was performed with Fisher’s
exact test for categorical variables, and Wilcoxon rank sum
test for continuous variables like age. Non parametric test-
ing was used in all continuous variables as we did not
assume any normal distribution in these variables. Multiva-
riable logistic regression models were used to evaluate
dichotomous outcomes, such as 30-day mortality. Cox
proportional hazard models were used to analyze time-
dependent outcomes. Subanalyses were performed using
propensity score models to control for potential unknown
confounding variables associated with clamp position. An
alpha value of 0.05, corresponding to P  .05 and 95%
confidence intervals (CI), were used as the criterion for
statistical significance. Data analysis was performed using
SAS version 9.1 (SAS Institute Inc, Cary, NC).
The propensity score approach provides a conceptual
model for causal inference in observational studies.9 Expo-
sure groups in non-randomized studies may differ with
respects to variables that may influence outcomes and any
observed differences may be due to these variables. There-
tion p
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the biases associated with an SR cross-clamp in this non-
randomized group of patients. Aside from the anatomy of
the aneurysm being the primary guiding factor in the
position of the cross-clamp, there may be hidden unknown
variables that influence this decision. These hidden factors
would be controlled for by a randomized trial design. In
this case of a non-randomized patient population, the
propensity score is a statistical method to control for these
hidden factors in the two groups. Cox proportional hazard
test was used utilizing the propensity score for the likeli-
hood of SR cross-clamp to evaluate mortality risks. This
analysis provides for a check against the routine multivari-
able analysis with the addition of the propensity score in an
attempt to control for unknown variables that may affect
the position of the cross-clamp. The variables included in
our propensity score model are similar to those included in
the multivariable analysis model.
RESULTS
General. From January 1, 1990, through December
31, 2006, 1020 open non-ruptured AAA repairs were
performed at the Brigham and Women’s Hospital. The
mean age of the patients was 70.9 years. There were 804
males (78.8%) and 216 females (21.2%) in the group. A
total of 849 (83.2%) were done with an IR aortic cross-
clamp; 171 (16.8%) were done with an SR aortic cross-
clamp of which 54 (31.6%) required an adjunctive renal
artery procedure. These adjunctive renal artery procedures
included 37 renal endarterectomies, 12 renal artery reim-
plantations, and 11 aortorenal bypasses. There were pro-
portionally more males in the SRRRP group (81%) than
the SRRRP group (61%, P .005). In the SR group, 39
patients (23%) had supraceliac cross-clamping and 132
patients (77%) had an SR cross-clamp based on anatomic
factors and the surgeon’s discretion. The propensity for
patients to get an SR clamp was influenced by the presence
of hypertension (odds ratio [OR] 1.55, 1.06-2.28, P 
Table I. Baseline demographics, risk factors, and operativ
Overall
IR
(n  849)
Age (years) 70.9 70.9
Gender (male) 804 (78.8%) 676 (79.6%)
Diabetes 102 (10.0%) 77 (9.1%)
Smoking 346 (33.9%) 279 (32.9%)
Hypertension 641 (62.8%) 521 (61.4%)
Coronary artery disease 524 (51.4%) 429 (50.5%)
Cerebrovascular disease 90 (8.8%) 71 (8.4%)
Chronic pulmonary disease 165 (16.2%) 134 (15.8%)
Chronic renal failure 64 (6.3%) 40 (4.7%
Congestive heart failure 68 (6.7%) 56 (6.6%)
Size of aneurysm 5.7 cm 5.6 cm
Mean EBL (mL) 1368 1257
IR, Infrarenal; SR, suprarenal; SRRRP, suprarenal with renal revasculariza
EBL, estimated blood loss..024), preoperative renal failure (OR 3.13, 1.62-6.03, P.0007) and increased size of the aneurysm (OR 1.31,
1.15-1.49, P  .0001).
The mean follow-up interval was 57.6 months. A total
of 250 (25%) were considered lost to follow-up (defined as
having no patient contact for more than 18 months from
last contact) for the purpose of long-term survival evalua-
tion. Our routine follow-up schedule for open AAA repair
patients would be a postoperative visit at 1 week, 1 month,
and then routine follow-up at 1 year and subsequently at 5
years, unless there are problems encountered. For this
study, we reviewed the information available from the
social security death index to check if the patients in this
study were still alive.
Baseline risk factors are depicted in Table I. Of note,
the prevalence of diabetes (14.6% vs 9.1%, P  .027),
hypertension (70.2% vs 61.4%, P  .03) and chronic renal
failure defined as baseline creatinine 2.0 mg/dL or dial-
ysis dependence (14.0% vs 4.7%, P  .0001) are all higher
in the SR vs IR group. No other significant differences were
noted between the IR and SR groups. There were no
significant differences between the SRRRP and SRRRP
groups.
The overall mean aneurysm size was 5.7 cm. Aneurysms
in the SR group were significantly larger than those in the
IR group (6.0 cm vs 5.6 cm, P .001). The aneurysm size
was also larger in the SRRRP group compared to the
SRRRP group (6.2 cm vs 5.6 cm, P  .015).
Mean estimated blood loss (EBL) was 1368 cc (100-
18,000 cc). The SR group had higher mean EBL compared
to the IR group (1919 cc vs 1257 cc, P  .001). Median
LOS was 8.0 days. It was shorter in the IR group compared
to the SR group (8.0 vs 9.0 days, P  .047). Those
requiring additional RRP in the SR group had longer
median LOS of 10.0 days compared to those who did not,
9.0 days (P  .018). In a multivariate analysis, only mean
EBL was associated with increased LOS (P  .001).
Perioperative mortality. The overall 30-day mortal-
ity rate was 1.2% for all patients. The SR group had a 30-day
iables
SR
171) P values
SRRRP
(n  54)
SRRRP
(n  117) P values
1.0 .18 70.8 71.2 .80
(74.8%) .16 33 (61.1%) 95 (81.2%) .005
(14.6%) .27 10 (18.5%) 15 (12.8%) .33
(39.2%) .11 25 (46.3%) 42 (35.9%) .20
(70.2%) .03 42 (77.8%) 78 (66.7%) .14
(55.6%) .23 25 (46.3%) 70 (59.8%) .10
(11.1%) .25 7 (13.0%) 12 (10.2%) .60
(18.1%) .45 9 (16.7%) 22 (18.8%) .74
(14.0%) .0001 9 (16.7%) 15 (12.8%) .22
(7.0%) .84 6 (11.1%) 6 (5.1%) .16
6.0 cm .001 5.6 cm 6.2 cm .015
9 .001 2133 1923 .57
rocedure; SRRRP, suprarenal without renal revascularization procedure;e var
(n 
7
128
25
67
120
95
19
31
24
12
191mortality of 1.8% vs 1.1% for the IR group (P  .44). The
tion p
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and the SRRRP group (1.8% vs 1.7%, P  NS). Multi-
variate analyses using logistic regression were performed to
evaluate factors associated with 30-day mortality. Thirty-
day death was associated with increased age (OR 1.18,
1.04-1.33, P  .009) and size of aneurysm (OR 1.72,
1.04-2.84, P  .034). Suprarenal cross-clamp position did
not increase the risk of 30-day death. In the Cox propor-
tional hazard model using the propensity score, the use of
an SR cross-clamp did not increase the risk of 30-day death
(OR 1.63, 0.43-6.12, P  NS).
General morbidity. Overall morbidity is shown in
Table II. Major adverse events were defined as myocardial
infarction, decline in renal function (doubling of pre-oper-
ative creatinine to value2 mg/dL or new-onset dialysis),
pneumonia, and stroke and occurred in 10.6% of all pa-
Fig 1. MAE rates. IR, Infrarenal; SR, suprarenal; SRRRP,
suprarenal with renal revascularization procedure; SRRRP, su-
prarenal without renal revascularization procedure.
Table II. Post-op morbidity
Overall
(n  1020)
IR
(n  849)
MI 26 (2.5%) 20 (2.4%)
Arrhythmia 90 (8.8%) 67 (8.0%)
Congestive heart failure 6 (0.6%) 5 (0.6%)
Peripheral emboli 11 (1.1%) 6 (0.7%)
Renal decline 36 (3.5%) 23 (2.8%)
Pneumonia 67 (6.6%) 52 (6.2%)
Stroke 7 (0.7%) 5 (0.6%)
Protracted ileus 47 (4.6%) 42 (5.0%)
Colonic ischemia 11 (1.1%) 7 (0.8%)
Gastrointestinal bleed 15 (1.5%) 10 (1.2%)
Pancreatitis 10 (1.0%) 6 (0.7%)
Hepatic failure 1 (0.1%) 1 (0.1%)
Reoperation for hemorrhage 13 (1.3%) 8 (1.0%)
Wound dehiscence 12 (1.2%) 8 (1.0%)
Deep venous thrombosis 7 (0.7%) 6 (0.7%)
Wound infection 13 (1.3%) 12 (1.4%)
Coagulopathy 2 (0.2%) 1 (0.1%)
Hematoma/seroma 11 (1.1%) 9 (1.1%)
IR, Infrarenal; SR, suprarenal; SRRRP, suprarenal with renal revasculariza
MI, myocardial infarction.tients. The IR group had MAEs in 9.5% of patients whilethe SR group had a higher rate of 17.0% (P .003). There
is a significant difference in the MAE in the SRRRP and
the SRRRP groups (25.9% vs 12.8%, P  .034) (Fig 1).
Multivariate analysis of factors associated withMAEs shows
an association with smoking (OR 2.15, 1.03-4.46, P 
.04) and increasing age (OR 1.07, 1.02-1.13, P  .004).
The use of an SR cross-clamp was not associated with
MAEs (OR 0.49, 0.16-1.54, P  NS). Propensity score
data confirms this finding that the SR cross-clamp was not
associated with increased MAEs (OR 0.83, 0.37-1.87, P
NS) but did decrease the risk of complications (OR 0.55,
0.38-0.78, P  .0008).
Renal function. The mean values of serum creatinine
were higher in the SR group at points of pre-operation and
discharge (P  .001) (Table III). This effect was similar
when comparing the SRRRP and SRRRP groups to the
IR group. Between the two SR groups of SRRRP and
SRRRP, there was no statistical difference in creatinine
values at all time points. Within the SRRRP group how-
ever, those patients with a normal creatinine at baseline had
a significant increase in creatinine at discharge (1.3 mg/dL
preoperation vs 1.7 mg/dL at discharge, P  .014). This
SR
171) P values
SRRRP
(n  54)
SRRRP
(n  117) P values
3.5%) .20 4 (7.4%) 2 (1.7%) .14
13.4%) .019 9 (16.7%) 14 (12.0%) .40
0.6%) 1.0 0 (0%) 1 (0.8%) .50
2.9%) .01 2 (3.7%) 3 (2.6%) .07
7.6%) .002 8 (14.8%) 5 (4.3%) .016
8.8%) .12 9 (16.7%) 6 (5.1%) .013
1.2%) .53 0 (0%) 2 (1.7%) .33
2.9%) .25 1 (1.8%) 4 (3.4%) .57
2.3%) .08 3 (5.6%) 1 (0.8%) .06
2.3%) .23 2 (3.7%) 2 (1.7%) .42
2.3%) .048 2 (3.7%) 2 (1.7%) .42
0%) NS 0 (0%) 0 (0%) NS
2.9%) .035 3 (5.6%) 2 (1.7%) .17
2.3%) .12 3 (5.6%) 1 (0.8%) .06
0.6%) .86 0 (0%) 1 (0.8%) .50
0.6%) .38 0 (0%) 1 (0.8%) .50
0.6%) .21 0 (0%) 1 (0.8%) .50
1.2%) .90 2 (3.7%) 0 (0%) .036
rocedure; SRRRP, suprarenal without renal revascularization procedure;
Table III. Creatinine values (mg/dL)
IR SR
P
values
SR
RRP
SR
RRP
P
values
Pre-operation 1.3 1.5 0.001 1.5 1.6 .64
Discharge 1.2 1.6 0.001 1.8 1.5 .08
P  NS for all comparisons within groups between preoperation and
discharge.
IR, Infrarenal; SR, suprarenal; SRRRP, suprarenal with renal revascular-
ization procedure; SRRRP, suprarenal without renal revascularization
procedure.(n 
6 (
23 (
1 (
5 (
13 (
15 (
2 (
5 (
4 (
4 (
4 (
0 (
5 (
4 (
1 (
1 (
1 (
2 (contrasts with the SRRRP group where there was no
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and at discharge for both the high and normal baseline
creatinine groups.
The SR group had a higher rate of decline in renal
function (doubling of creatinine from preoperative levels to
a value2 mg/dL or new-onset dialysis) at 7.6% vs the IR
group at 2.7% (P  .002). The SRRRP group had a
significantly higher rate of postoperative renal decline rate
at 14.8% vs 4.3% in the SRRRP group (P  .016). It is
noteworthy that the rates of postoperative decline in renal
function are similar for the IR group vs the SRRRP group
(2.7% vs 4.3%, P .34) (Table IV). Multivariate regression
models show that preoperative renal failure (OR 8.15,
2.92-22.8, P  .0001) and increased EBL (OR 1.00,
1.00-1.00, P  .013) were associated with postoperative
renal decline. The SR cross-clamp did not influence this
result (OR 2.01, 0.81-4.97, P .13). However, propensity
score analysis showed that the use of an SR cross-clamp was
associated with postoperative renal decline (OR 2.66, 1.28-
5.50, P  .009).
Of note, in the SR group, there was only 1 patient who
required permanent dialysis postoperatively (0.6%). This
patient had a normal baseline creatinine of 1.0 mg/dL
preprocedure. In the IR group, 7 patients needed perma-
nent new-onset dialysis (0.8%). Three of these 7 patients
had pre-existing renal failure (mean creatinine of 2.4
mg/dL preoperatively). The remaining 4 patients had a
mean preoperative creatinine of 1.5 mg/dL.
Using GFR (mL/minute/1.73m2) as a measure of
renal function, patients were grouped into those with GFR
60, GFR between 30 and 60, and GFR 30 preopera-
tively and postoperatively. Table V shows the distribution
of patients. In univariate analysis, preoperative renal failure
(GFR 30 mL/minute/1.73m2) was more common in
the SR group vs the IR group (15.8% vs 4.7%, P  .001).
Postoperative renal failure (GFR 30 mL/minute/
1.73m2 and a 20% decrease from preoperative GFR lev-
els) was also more common in the SR vs IR group (10.5% vs
4.8%, P  .004). Looking at the SR subgroups, SRRRP
had a higher rate of renal failure compared to the IR group
(16.7% vs 4.8%, P  .001) whereas SRRRP compared to
IR group did not (7.7% vs 4.8%, P  .19). The rates of
preoperative renal failure were similar between the
SRRRP and SRRRP groups (22.2% vs 12.8%, P .12).
In multivariable analysis, decline in discharge GFR was
associated with preoperative GFR (OR 9.62, 5.69-16.3,
Table IV. Impact on renal function
IR SR
Preoperative renal failure 40 (4.7%) 24 (14.0)
Postoperative renal decline 23 (2.8%)* 13 (7.6%)
New-onset dialysis 7 (0.8%) 1 (0.6%)
IR, Infrarenal; SR, suprarenal; SRRRP, suprarenal with renal revasculariza
*P  .34.P  .0001), the use of an SR clamp (OR 3.16, 2.04-4.91,P  .0001) and increasing age (OR 1.04, 1.02-1.07, P 
.0003).
Long term survival. Five-year survival was 69.1% 
1.9% for the IR group and 67.7% 4.3% for the SR group
(P  .38) (Fig 2). Multivariate analysis of baseline risk
factors show female gender was protective of overall sur-
vival (hazard ratio [HR] 0.72, 0.55-0.93, P  .011). The
presence of coronary artery disease (HR 1.36, 1.08-1.72,
P .009), chronic obstructive pulmonary disease (COPD)
(HR 1.59, 1.21-2.09, P  .0009), chronic renal failure
(HR 2.87, 1.90-4.33, P  .0001), congestive cardiac fail-
ure (HR 2.52, 1.78-3.57, P  .0001), increased age (HR
1.05, 1.03-1.06, P  .0001), and size of aneurysm (HR
1.10, 1.03-1.18, P  .008) were associated with increased
P value SRRRP SRRRP P value
.001 9 (16.7%) 15 (12.8%) .71
.002 8 (14.8%) 5 (4.3%)* .02
.91 0 (0%) 1 (0.9%) NS
rocedure; SRRRP, suprarenal without renal revascularization procedure.
Table V. Association of preoperative and postoperative
GFR
Preoperative GFR Postoperative GFR
Overall
30 (n  60) 30 43 (71.7%)
30-60 16 (26.7%)
60 1 (1.7%)
30-60 (n  521) 30 37 (7.1%)
30-60 308 (59.1%)
60 176 (33.8%)
60 (n  439) 30 3 (0.7%)
30-60 69 (15.7%)
60 367 (83.6%)
Infrarenal group
30 (n  34) 30 24 (70.6%)
30-60 9 (26.5%)
60 1 (2.9%)
30-60 (n  436) 30 25 (5.7%)
30-60 253 (58.0%)
60 1 (2.9%)
60 (n  379) 30 2 (0.5%)
30-60 47 (12.4%)
60 330 (87.1%)
Suprarenal group
30 (n  26) 30 19 (73.1%)
30-60 7 (26.9%)
60 0 (0%)
30 (n 85) 30 12 (14.1%)
30-60 55 (64.7%)
60 18 (21.2%)
60 (n  379) 30 1 (1.7%)
30-60 22 (36.7%)
60 37 (61.74%)
GFR, Glomerular Filtration Rate (mL/minute/1.73m2).long-term mortality. The use of an SR cross-clamp was not
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P  .09). Propensity score analysis did not associate long-
term survival with the use of an SR cross-clamp (HR 1.2,
0.98-1.53, P  .12).
DISCUSSION
Open repair of AAA has been well described in many
series and has been established as an effective and durable
procedure.10 Differences in operative technique such as
transperitoneal vs retroperitoneal exposure have not
yielded major differences.11 At our institution, the wide-
spread use of endovascular AAA stent graft repair has
increased the relative complexity of open AAA repair. Pro-
portionally, more of these open operations now require an
SR cross-clamp to repair aneurysms which are increasingly
juxtarenal, pararenal, or SR in nature. In light of this
change in operative pattern, we undertook this review of
our current experience with SR cross-clamping for aneurys-
mal repair. This review also helps establish a potential
benchmark against which emerging endovascular technol-
ogies for juxtarenal and SR aneurysm may be compared.
The literature on SR cross-clamping for open aneurysm
repair began from 1986 with Crawford et al1 reporting on
their experience with 101 patients. That report was focused
primarily on diagnostic considerations to identify AAA
patients requiring an SR cross-clamp but also described the
sequelae from the SR cross-clamp.1 The mortality rate was
7.9% and the dialysis rate was 8%. In general, these reports
confirmed increased morbidity and mortality compared to
aneurysm repair with IR cross-clamping. Shepard et al12
reported a series of 23 patients requiring an SR cross-clamp
for repair of AAA and noted a 4% early mortality rate. More
recently in 1999, Jean-Claude et al13 reviewed the experi-
ence at theUniversity of California – San Francisco (UCSF)
of 257 is the largest reported series thus far. Of these
patients, 180 were operated on for pure aneurysmal disease
while the remaining 77 had combined aneurysmal disease
Fig 2. Long term survival. Standard error at all time points were
10% for all groups shown. IR, Infrarenal; SR, suprarenal;
SRRRP, suprarenal with renal revascularization procedure;
SRRRP, suprarenal without renal revascularization procedure.and renal artery occlusive disease. They found 5.8% overallmortality rate and a new-onset dialysis rate of 4.3%. The
most frequent postoperative morbidity included a 7.4%
incidence of developed respiratory insufficiency and a 5.8%
incidence of myocardial infarction. Green et al14 looked at
difficult dissections of the aortic cuff and concluded that
supraceliac clamping was preferable to SR clamping and
resulted in lower mortality and postoperative renal failure
rates. For SR clamping, they had an early mortality rate of
32% and a dialysis rate of 23%, whereas in supraceliac
clamping, the rates were only 3% for both events.
More recently, Shortell et al15 found no relationship
between clamp placement (supraceliac vs IR) and any of the
major outcomes parameters and a 6% overall mortality rate
in elective juxtarenal aortic aneurysm repair. Knott et al16
reported on 126 patients at the Mayo Clinic requiring SR
cross-clamping for AAA repair and had a 0.8% 30-day
mortality and postoperative renal insufficiency rate of 18%.
Their 5-year cumulative survival rate was 63.8% which is
very similar to our series, mortality was not predicted by any
specific risk factor in their analysis.
The results of the current review are encouraging in
that they have established that these complex operations
may be performed with morbidity and mortality similar to
standard open repair with an IR cross-clamp. The 1.8%
30-day mortality rate in this series for the SR group com-
pares favorably to that previously reported in the literature
and did not differ significantly from the 1.1% rate with IR
cross-clamping in this series. Operative blood loss (1919 vs
1257 cc), length of stay (12.6 vs 10.7 days), and MAE rate
(17% vs 9.5%) were all higher in the SR group. Multivariate
analysis, however, confirmed that factors other than clamp
position (ie, smoking history and age) were the major
predictors of MAEs. It is reassuring that SR patients,
despite increased co-morbidities at base line (Table I)
and increased perioperative MAEs enjoyed nearly iden-
tical long-term survival to those patients undergoing IR
repairs (69.1  1.9% for the IR group and 67.7  4.3%
for the SR).
It was gratifying to establish the relative preservation of
renal function in patients undergoing SR cross-clamping.
The rate of new-onset dialysis, which was 0.8% for the SR
group, is low compared to the historic literature and similar
to the 0.6% rate for our IR patients. The SR group, how-
ever, had a higher rate of decline in renal function (dou-
bling of creatinine from preoperative levels to a value 2
mg/dL or new-onset dialysis) at 7.6% vs the IR group at
2.7%. The propensity score analysis confirmed the SR
clamp position was an independent predictor of postoper-
ative decline in renal function. Subgroup analysis, however,
confirmed that postoperative decline in renal function was
significantly more likely in the SRRRP group than the
SRRRP group (14.8% vs 4.3%). Conversely SR cross-
clamp without the need for direct renal artery intervention
could be performed with declines in renal function similar
to the IR group (4.3% vs 2.7%, P  .34).
Several formulas have been used to calculate GFR. In
the past, the Cockcroft-Gault formula has been most pop-
ular; more recently the MDRD equation proposed by
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GFR values in this context, multivariate logistic regression
analysis show that preoperative GFR is strongest predictor
of postoperative GFR and the use of SR clamp was weaker.
The results reported here offer an updated benchmark
against which new technologies may be compared. Early
reports of fenestrated and branched stent grafts offer endo-
vascular options for many of the patients treated with open
SR repair such as those reported in this series. Muhs et al17
reviewed their results from 38 patients who underwent
endovascular AAA repair with branched or fenestrated en-
dografts and found a 2.6% 30-day mortality rate with a 13%
1-year mortality rate. They reported a postoperative renal
failure rate of 5.2% (defined as a creatinine increase more
than 50% from preoperative levels). Haddad et al18 re-
viewed the experience at the Cleveland Clinic with fenes-
trated endografts and reported a 2.8% (2/72) long-term
dialysis rate. Another 2/72 (2.8%) of patients required
transient dialysis postoperatively. Their reported 1-year
mortality was 6.9% (5/72).
In a systematic review of the literature by Sun et al19
selecting six studies published on the results of fenestrated
endovascular AAA grafts between 1999 and 2006, 13.3%
(4.1%-22.5%) of patients had postprocedural renal dysfunc-
tion and 30-day mortality was 1.1% (0.4%-2.7%). They
noted a correlation between preoperative renal insuffi-
ciency and postprocedural renal dysfunction, but due to the
lack of sample size, it did not reach statistical significance
(P  .2). The early reports of endovascular repair of aneu-
rysms using branched and fenestrated grafts thus offer en-
couraging results. They clearly represent highly selected pa-
tients from specialized centers, but nonetheless have achieved
results comparable to the SR group reported in this series.
The presence of renal artery occlusive disease and an
AAA presents an interesting therapeutic dilemma. Options
include open treatment of the AAA with an SR cross-clamp
and repair of the renal lesion (with endarterectomy or
bypass) or staging the procedure with either preoperative
or postoperative angioplasty and stenting. Ballard et al20
reviewed 50 patients who had combined renal artery steno-
sis and AAA. Thirty-two had simultaneous operative aortic
and renal artery reconstruction; the remaining 18 had
preoperative percutaneous renal artery angioplasty. Statis-
tical analysis did not reveal any difference in preoperative
creatinine value, LOS, EBL, postoperative hypertension,
and postoperative creatinine. They concluded that preop-
erative percutaneous balloon angioplasty of the renal artery
had no specific advantage over simultaneous open repair in
patients with concomitant AAA. Our results corroborate
these findings. Suprarenal repair with simultaneous renal
reconstruction offers a safe and acceptable alternative. If,
however, technical factors identified at surgery would make
renal reconstruction difficult we do not hesitate to employ
postoperative angioplasty and stenting.
This study has characteristic limitations. Although data
was collected through a database in a prospective fashion,
the study design is retrospective in nature. The database
was not specifically designed for this study. The estimatedGFR is not well validated for use in acute renal injury and
although discharge creatinine is used here for this calcula-
tion, it is unclear how this value changes with time. In this
patient population, we do not have routine long-term
follow-up as these patients are not followed as closely as
patients with occlusive disease. As such, many of our pa-
tients are not seen outside of their 30-day, 1-year, and
subsequent 5-year follow-up. The social security death
index was used to evaluate long-term follow-up.
CONCLUSION
This study confirms that AAA repair with an SR cross-
clamp may be performed with a major morbidity and
mortality rate similar to repair with an IR cross-clamp and
with results superior to most historical series. Although
simultaneous renal artery reconstruction confers an addi-
tional amount decline in renal function, it is similarly well
tolerated with a minimal risk of postoperative dialysis.
These results are reassuring in that an increasing proportion
of open aneurysm repairs will require SR clamping. The
results suggest that the benefits of endovascular repair of
aneurysm with branched and fenestrated grafts must offer
low-morbidity and mortality rates as well as excellent pres-
ervation of renal function to offer incremental benefits over
open aneurysm repair with SR cross-clamp. Conversely, the
results with SR cross-clamping reported here were largely
achieved in an era where open IR aneurysm repair has been
relatively common (although decreasing due to increasing
endovascular repairs). It remains a concern whether future
vascular surgeons, who have focused largely on endovascu-
lar repair, will have the operative experience necessary to
perform aneurysm repairs with SR cross-clamping with
results similar to IR cross-clamping.
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